Ms. Dixon has 20 years of market access and reimbursement experience in the life science industry. She has previously served as vice president of government affairs and health economics and a member of the senior leadership team at Advanced BioHealing.
Osiris Therapeutics is a stem cell company focused on developing and marketing products to treat conditions in the wound care, orthopedic and sports medicine markets.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
